Early Infectious Disease Outpatient Follow-up of Outpatient Parenteral Antimicrobial Therapy Patients Reduces 30-Day Readmission.

Authors

• Ena Saini
• Mohammad Ali
• Ping Du
• Tonya Crook
• John Zurlo

Publication/Presentation Date

8-16-2019

Abstract

We conducted a case-control study to examine the association between outpatient infectious disease (ID) follow-up and risk of 30-day readmission in 384 patients receiving outpatient parenteral antimicrobial therapy. ID outpatient follow-up within 2 weeks was associated with lower risk of all-cause 30-day readmission (adjusted odds ratio, 0.33; P = .0001).

Volume

69

Issue

5

First Page

865

Last Page

868

ISSN

1537-6591

Published In/Presented At

Saini, E., Ali, M., Du, P., Crook, T., & Zurlo, J. (2019). Early Infectious Disease Outpatient Follow-up of Outpatient Parenteral Antimicrobial Therapy Patients Reduces 30-Day Readmission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69(5), 865–868. https://doi.org/10.1093/cid/ciz073

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

30721936

Department(s)

Administration and Leadership

Document Type

Article